How do we implement ANNEXXa-I into our Clinical Practice?

November 30, 2023

For acute care physicians, anticoagulated patients presenting with intracranial hemorrhage (ICH) is an incredibly challenging clinical scenario. ANNEXa-I is a randomized, controlled, clinical trial which provides clinicians with important information on appropriate reversal of anticoagualtion to optimally care for these patients.

0 Comments

Tweet Share

Real World Evidence for Management of Severe Bleeding in the Anticoagulated Patient: Impact of Specific Reversal Therapy for Intracranial Hemorrhage and Gastrointestinal Bleeding

July 28, 2023

Real World studies can provide the foundational support necessary for clinicians to effectively manage anticoagulated patients with severe, often life-threatening intracranial and gastrointestinal bleeding. While randomized controlled clinical trials have provided the initial data necessary for appropriate use of reversal agents such as andexanet alfa for Factor Xa associated bleeding, broader studies enrolling thousands of patients, many with significant co-morbidities, are extremely valuable to clinicians. New information regarding the randomized controlled trial ANEXXA-I, which was halted due to andexanet alfa efficacy, provides additional information supporting reversal therapy for severe bleeding.

0 Comments

Tweet Share

The Role of Real World Evidence in Driving Clinical Care for Anticoagulated Patients with Life-Threatening Bleeding

March 31, 2023

Experts in Emergency Medicine, Pharmacy, and Neurocritical Care describe the impact of real world evidence on the care of life-threatening bleeding in the anticoagulated patient. While clinical trial data remain the standard for clinicians, real world data provide important additional information on the use of a particular Repletion or Reversal therapy for these patients.

1 Comments

Tweet Share

What Are the Barriers to Success When Implementing Care Pathways for ICH Patients?

July 12, 2022

ICH remains deadly and pathways matter but they aren't always what we need and barriers can be overcome with knowledge.

0 Comments

Tweet Share

How Do We Coordinate Care Within Our Hospitals To Improve Outcomes in Hemorrhagic Stroke Patients?

July 5, 2022

Coordinating the necessary care for hemorrhagic patients is complicated- learn the ropes from experts on the UC Stroke Team. "Smoother, faster better" is the name of the game.

0 Comments

Tweet Share

RSS

1 2 3 4 5 6 7 8 9 10 Next Last

Dec 2

When Might You Use Heparin in the NeuroICU for a Stroke Patient?

Brian Gibler posted on 12/2/2020

Moderator:William A. Knight IV, MD, FACEP, FNCS
Other Participants: Kyle B. Walsh, MD, MS

Heparin in stroke remains controversial. Understanding the history and data and essential to mastering stroke care.

Dr. Kyle Walsh, an Emergency Medicine trained Neurointensivist, researcher and stroke physician shares his expertise with Dr. Bill Knight as they discuss heparin in stroke care. Not all heparin is bad, but its use has been deemphasized over the years. What are the data and how do they inform the use of heparin in acute stroke? Moreover, is heparin in acute ischemic stroke really dead?

0 Comments

Please login or register to post comments.

The Role of Real World Evidence in Driving Clinical Care for Anticoagulated Patients with Life-Threatening Bleeding

March 31, 2023

Experts in Emergency Medicine, Pharmacy, and Neurocritical Care describe the impact of real world evidence on the care of life-threatening bleeding in the...

1 Comments

Posterior Circulation Horror Stories: How To Save the Day and Your Patient

March 22, 2022

Posterior circulation strokes are often devastating. The diagnostics are different and the treatments are evolving. If you care for stroke patients, this...

0 Comments